We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Challenges and Opportunities With Oncology Drug Development in China.
- Authors
Bajaj, Gaurav; Gupta, Manish; Wang, Hwei‐Gene Heidi; Barrett, Jeffrey S.; Tan, Matthew; Rupalla, Katrin; Bertz, Richard; Sheng, Jennifer
- Abstract
Cancer is a growing public health problem in China. Despite the high unmet medical need of patients with cancer in China, oncology drug approvals have historically lagged behind those in the West, mainly the United States and Europe. China is currently undertaking regulatory reforms at a fast pace in order to mitigate this lag.
- Subjects
CHINA; CANCER patients; PUBLIC health; ONCOLOGY; DRUGS; REGULATORY reform
- Publication
Clinical Pharmacology & Therapeutics, 2019, Vol 105, Issue 2, p363
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1002/cpt.1017